Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma
Status:
Unknown status
Trial end date:
2019-01-27
Target enrollment:
Participant gender:
Summary
Evaluation of the safety and effectiveness of metformin as an adjunct to RCHOP chemotherapy
for patients with newly diagnosed diffuse large-B cell lymphoma